Ikena Oncology (IKNA) to Release Quarterly Earnings on Monday

Ikena Oncology (NASDAQ:IKNA - Get Free Report) will likely be releasing its Q1 2025 earnings data before the market opens on Monday, May 12th. Analysts expect Ikena Oncology to post earnings of ($0.21) per share for the quarter.

Ikena Oncology (NASDAQ:IKNA - Get Free Report) last announced its quarterly earnings data on Tuesday, March 11th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.05. On average, analysts expect Ikena Oncology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Ikena Oncology Price Performance

IKNA traded down $0.03 during midday trading on Wednesday, reaching $1.09. 219,175 shares of the company's stock traded hands, compared to its average volume of 169,468. The firm has a fifty day moving average of $1.24 and a two-hundred day moving average of $1.47. The stock has a market capitalization of $52.60 million, a price-to-earnings ratio of -0.89 and a beta of 0.47. Ikena Oncology has a 52 week low of $0.97 and a 52 week high of $1.94.

Ikena Oncology Company Profile

Ikena Oncology, Inc operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway.